| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |